February 2023 - current: Assistant Professor in the "Genome Biology and Epigenetics" division.
March 2017 - December 2022: Postdoctoral researcher in the Adelman laboratory at Harvard Medical School. During my postdoctoral work, I developed the INSERT-seq methodology to test whether the transcribed sequence affects the elongation potential of RNA Polymerase II, and obtained new insights into the sequence elements that contribute.
November 2010 - November 2016: PhD student in the Van Leeuwen laboratory at the Netherlands Cancer Institute. PhD degree awarded by the University of Amsterdam in March 2017. During my PhD, I studied the function and regulation of Dot1/DOT1L, the enzyme that methylates histone H3 lysine 79. To this end I developed Epi-ID, a new approach to identify chromatin regulators, and used various approaches in both yeast and mice to identify a conserved regulatory mechanism.
2016: MSc degree (cum laude) Drug Discovery & Safety, VU University in Amsterdam. During my MSc, I completed an internship at the VU studying dimerization of (viral) chemokine receptors with dr. Henry Vischer, and an internship at IDIBELL in Barcelona studying the epigenetic regulation of transcription factors in B cells.
2014: BSc degree (cum laude) Pharmaceutical Sciences, VU University in Amsterdam.
